Pharmacokinetics of Selected Antiinfectives During Sustained Low-efficiency Dialysis (SLED)
NCT02287493 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2021-12-14
Summary
In a prospective, non-interventional, monocentric observational study the pharmacokinetic properties of selected antiinfective drugs during sustained low-efficiency dialysis (SLED) will be analyzed.
Conditions
- Replacement Therapy, Renal
Interventions
- OTHER
-
Pharmacokinetic Analysis
Sponsors & Collaborators
-
Universitätsklinikum Hamburg-Eppendorf
lead OTHER
Principal Investigators
-
Stefan Kluge, Prof. Dr. · University Medical Center Hamburg-Eppendorf, Department of Intensive Care
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2016-12-31
- Completion
- 2016-12-31
Countries
- Germany
Study Locations
More Related Trials
-
Protein-bound Uremic Retention Solutes and Long Nocturnal Hemodialysis: a Longitudinal Analysis
NCT00417339 ·Status: COMPLETED
-
Effect of Sodium and UF Profiling on Dialysis
NCT06213129 ·Status: NOT_YET_RECRUITING
-
Retrospective Analysis of Performance and Treatment Data Collected for Genius SleddFlux Filter, Ultraflux AV 600 S Filter & Genius 90 Concentrates in Haemodialysis Patients
NCT05282732 ·Status: RECRUITING
-
Concentration of Ampicillin / Sulbactam and Amoxicillin / Clavulanic Acid in the Blood During Renal Replacement Therapy in Longterm Renal Replacement Therapy Patients
NCT02007603 ·Status: COMPLETED ·Phase: PHASE3
-
Microcirculation During Haemodialysis
NCT01396980 ·Status: COMPLETED
-
Cardiopulmonary Exercise Testing Parameters' Variability in Hemodialysis Patients.
NCT05557929 ·Status: COMPLETED
-
Effects of Variation of Sodium Dialysate in ICU
NCT03329313 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Compare Safety and Tolerability of AKST1210 Column at 2 Blood Flow Rates in Subjects With ESRD on Hemodialysis
NCT04985383 ·Status: COMPLETED ·Phase: NA
-
Serum Ceftazidime Concentrations in Hemodialysis Patients
NCT03634904 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux Hemodialysis
NCT03722381 ·Status: WITHDRAWN
-
The Use of Furosemide in Patients on Dialysis
NCT01815892 ·Status: UNKNOWN ·Phase: PHASE4
-
Biological Effects of Citrate-buffered Solutions on Dialysis Efficiency and Systemic Inflammation
NCT03577249 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hemodialysis Blood Flow and Urea Clearance
NCT02484118 ·Status: COMPLETED ·Phase: NA
-
A Subjective Evaluation of Inflow Pain Associated With the Use of an Experimental Solution for Peritoneal Dialysis
NCT00214695 ·Status: COMPLETED ·Phase: NA
-
Interdialytic Peritoneal UltraFiltration in HemoDialysis Patients
NCT04603014 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal Disease
NCT01721421 ·Status: UNKNOWN ·Phase: NA
-
Clearance and Pharmacokinetics of Antibiotics in Renal Replacement Therapy
NCT03714789 ·Status: COMPLETED
-
Hannover Dialysis Outcome Study
NCT00529139 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Nighttime Dialysis on the Inflammation of Kidney Failure
NCT00234130 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Assessments of NeoKidney® in ESRD Patients Treated With Short Daily Hemodialysis
NCT06024135 ·Status: UNKNOWN ·Phase: NA
-
Non- Clinical Coagulation Activation During Hemodialysis
NCT04063423 ·Status: COMPLETED
-
EXtension of Tablo TrEatmeNt Duration Registry
NCT04912050 ·Status: COMPLETED
-
Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients
NCT00912821 ·Status: COMPLETED ·Phase: PHASE4
-
Saline Versus Albumin Fluid for Extracorporeal Removal With Slow Low Efficiency Dialysis Feasibility Study
NCT03665311 ·Status: COMPLETED ·Phase: PHASE2
-
Intradialytic Drug Removal by Short-daily Hemodialysis
NCT00596167 ·Status: COMPLETED ·Phase: NA